Division of CVS Health Corp.
Latest From Aetna Inc.
Recent mergers between PBMs and insurers should address one long-term strategic objective of pharma – the recognition by payors of the value of biopharmaceutical products in relation to other medical costs.
US Action Collaborative plans to align guidelines for acute and chronic pain indications; panelist at public meeting questions whether focus should be on pain management rather than opioids.
The proposal to eliminate rebates in the US raises important follow up questions, including who will be responsible for pharmacy transactions at the point of sale. PBMs say they should stay in that role to assure a smooth transition; independent pharmacies have other ideas.
Faced with a proposed regulation that aims to eliminate rebates and an upcoming hearing on Capitol Hill, US pharmacy benefit managers including OptumRx are working to validate the concept of rebates when redirected to patients at the point-of-sale.
- Therapeutic Areas
- North America
- Parent & Subsidiaries
- CVS Health Corp.
- Senior Management
Mark W Bertolini, Chmn. & CEO
Shawn M Guertin, EVP, CFO & Chief Enterprise Risk Officer
Harold L Paz, MD, EVP & CMO
- Contact Info
Phone: (860) 273-0123
151 Farmington Ave.
Hartford, CT 06156
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.